{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T10:57:48Z","timestamp":1693393068356},"reference-count":35,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2004,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The recent availability of numerous well-characterized<jats:italic>Mycobacterium tuberculosis<\/jats:italic>recombinant proteins has revived interest in the serological diagnosis of tuberculosis. Several promising results have been reported, particularly when more than one antigen is used in the test. However, thus far these antigens have not been used in routine diagnostic tests because they lack sufficient sensitivity. In addition, with the exception of one antigen, most recombinant<jats:italic>M. tuberculosis<\/jats:italic>proteins do not identify the majority of tuberculosis patients coinfected with human immunodeficiency virus (HIV). Here, we report a newer<jats:italic>M. tuberculosis<\/jats:italic>protein that is a promising candidate for increasing the sensitivity of the serological tests, in particular for patients coinfected with HIV. The protein was found in the urine of mice during the early stages of infection with<jats:italic>M. tuberculosis<\/jats:italic>(10 to 14 days), thus suggesting that the antigen is abundantly released during the in vivo growth of the mycobacterium. Reverse genetics was used to produce the recombinant protein, which we named U1 (for urine protein 1). Using a conventional enzyme-linked immunosorbent assay (ELISA), antibody to U1 could be detected in 60% of patients with pulmonary tuberculosis with no signs of coinfection with HIV (<jats:italic>n<\/jats:italic>= 83). Conversely, anti-U1 antibody was detected in 87% of the sera from tuberculosis patients coinfected with HIV (<jats:italic>n<\/jats:italic>= 47). Out of 12 HIV-infected nontuberculosis patients' sera, 9 did not react with U1 and three sera gave borderline ELISA signals (signal\/cutoff of \u22641.75). These results suggest that the high efficiency of U1 in identifying tuberculosis patients coinfected with HIV may be related to abundant release of this protein during the initial phase of the HIV coinfection. The immediate availability of the antigen at a time point in which the patient's immune system is still competent would lead to a secondary immune response to U1 that persists for months in the patient's serum.<\/jats:p>","DOI":"10.1128\/cdli.11.2.280-286.2004","type":"journal-article","created":{"date-parts":[[2004,3,10]],"date-time":"2004-03-10T20:13:13Z","timestamp":1078949593000},"page":"280-286","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Potential Serological Use of a Recombinant Protein That Is a Replica of a<i>Mycobacterium tuberculosis<\/i>Protein Found in the Urine of Infected Mice"],"prefix":"10.1128","volume":"11","author":[{"given":"Sandeep","family":"Mukherjee","sequence":"first","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Daifalla","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanni","family":"Zhang","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Douglass","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Brooks","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Vedvick","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Houghton","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Campos-Neto","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Institute"},{"name":"Corixa Corporation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"356","volume":"124","year":"1981","unstructured":"American Thoracic Society. 1981. The tuberculin skin test. Am. Rev. Respir. Dis.124:356-363.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_3_2","first-page":"725","volume":"142","year":"1991","unstructured":"American Thoracic Society and Centers for Disease Control. 1991. Diagnostic standards and classification of tuberculosis. Am. Rev. Respir. Dis.142:725-735.","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_4_2","first-page":"676s","volume":"20","year":"1995","unstructured":"Bothamley, G. H. 1995. Serological diagnosis of tuberculosis. Eur. Respir. J. Suppl.20:676s-688s.","journal-title":"Eur. Respir. J. Suppl."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-3083.2001.00975.x","volume":"54","year":"2001","unstructured":"Brusasca, P. N., R. Colangeli, K. P. Lyashchenko, X. Zhao, M. Vogelstein, J. S. Spencer, D. N. McMurray, and M. L. Gennaro. 2001. Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand. J. Immunol.54:448-452.","journal-title":"Scand. J. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1054\/tube.2001.0311","volume":"81","year":"2001","unstructured":"Campos-Neto, A., V. Rodrigues-Junior, D. B. Pedral-Sampaio, E. M. Netto, P. J. Ovendale, R. N. Coler, Y. A. Skeiky, R. Badaro, and S. G. Reed. 2001. Evaluation of DPPD, a single recombinant Mycobacterium tuberculosis protein as an alternative antigen for the Mantoux test. Tuberculosis (Edinburgh)81:353-358.","journal-title":"Tuberculosis (Edinburgh)"},{"key":"e_1_3_2_7_2","first-page":"1423","volume":"182","year":"1999","unstructured":"Campos-Neto, A., L. Soong, J. L. Cordova, D. Sant'Angelo, Y. A. W. Skeiky, N. H. Ruddle, S. G. Reed, Jr., C. A. Janeway, and D. McMahon-Pratt. 1999. Cloning and expression of a Leishmania donovani instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J. Exp. Med.182:1423-1433.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1054\/tuld.2000.0243","volume":"80","year":"2000","unstructured":"Chan, E. D., L. Heifets, and M. D. Iseman. 2000. Immunologic diagnosis of tuberculosis: a review. Tuber. Lung Dis.80:131-140.","journal-title":"Tuber. Lung Dis."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1164\/ajrccm.156.3.9607122","volume":"156","year":"1997","unstructured":"Chiang, I. H., J. Suo, K. J. Bai, T. P. Lin, K. T. Luh, C. J. Yu, and P. C. Yang. 1997. Serodiagnosis of tuberculosis. A study comparing three specific mycobacterial antigens. Am. J. Respir. Crit. Care Med.156:906-911.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/315677","volume":"182","year":"2000","unstructured":"Coler, R. N., Y. A. Skeiky, P. J. Ovendale, T. S. Vedvick, L. Gervassi, J. Guderian, S. Jen, S. G. Reed, and A. Campos-Neto. 2000. Cloning of a Mycobacterium tuberculosis gene encoding a purified protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity. J. Infect. Dis.182:224-233.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.9.3285-3290.2000"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","volume":"282","year":"1999","unstructured":"Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA282:677-686.","journal-title":"JAMA"},{"key":"e_1_3_2_13_2","first-page":"373","volume":"77","year":"1989","unstructured":"Espitia, C., I. Cervera, R. Gonzalez, and R. Mancilla. 1989. A 38-kD Mycobacterium tuberculosis antigen associated with infection. Its isolation and serologic evaluation. Clin. Exp. Immunol.77:373-377.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_14_2","first-page":"128","volume":"113","year":"1998","unstructured":"Ginsberg, A. M. 1998. The tuberculosis epidemic. Scientific challenges and opportunities. Public Health Rep.113:128-136.","journal-title":"Public Health Rep."},{"key":"e_1_3_2_15_2","first-page":"208","volume":"27","year":"1995","unstructured":"Gupta, S., R. Bhatia, and K. K. Datta. 1995. Serodiagnosis of tuberculosis. J. Commun. Dis.27:208-214.","journal-title":"J. Commun. Dis."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0962-8479(95)90008-X","volume":"76","year":"1995","unstructured":"Gupta, S., S. Kumari, J. N. Banwalikar, and S. K. Gupta. 1995. Diagnostic utility of the estimation of mycobacterial antigen A60 specific immunoglobulins IgM, IgA and IgG in the sera of cases of adult human tuberculosis. Tuber. Lung Dis.76:418-424.","journal-title":"Tuber. Lung Dis."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1073\/pnas.160270797","volume":"97","year":"2000","unstructured":"Gygi, S. P., G. L. Corthals, Y. Zhang, Y. Rochon, and R. Aebersold. 2000. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. USA97:9390-9395.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_18_2","first-page":"3","year":"1996","unstructured":"Haas, F., and S. S. Haas. 1996. The origins of Mycobacterium tuberculosis and the notion of its contagiousness, p. 3-19. In W. R. Rom and S. M. Garay (ed.), Tuberculosis. Little, Brown & Company, Boston, Mass.","journal-title":"Tuberculosis"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.6.2354-2361.2000"},{"key":"e_1_3_2_20_2","first-page":"540","volume":"18","year":"1992","unstructured":"Hopewell, P. C. 1992. Impact of human immunodeficient virus infection on the epidemiology, clinical features, management and control of tuberculosis. Clin. Infect. Dis.18:540-547.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_21_2","first-page":"883","volume":"9","year":"2002","unstructured":"Houghton, R. L., M. J. Lodes, D. C. Dillon, L. D. Reynolds, C. H. Day, P. D. McNeill, R. C. Hendrickson, Y. A. Skeiky, D. P. Sampaio, R. Badaro, K. P. Lyashchenko, and S. G. Reed. 2002. Use of multiepitope polyproteins in serodiagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol.9:883-891.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","volume":"17","year":"1993","unstructured":"Huebner, R. E., M. F. Schein, and J. B. Bass, Jr. 1993. The tuberculin skin test. Clin. Infect. Dis.17:968-975.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(91)90017-M","volume":"72","year":"1991","unstructured":"Kochi, A. 1991. The global tuberculosis situation and the control strategy of the World Health Organization. Tubercle72:1-6.","journal-title":"Tubercle"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.7.2485-2493.2001"},{"key":"e_1_3_2_25_2","first-page":"146","volume":"20","year":"1912","unstructured":"Mantoux, M. C. 1912. La vioe intradermique en tuberculinatherapie. Presse Med.20:146-148.","journal-title":"Presse Med."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1574-6968.2001.tb10615.x","volume":"198","year":"2001","unstructured":"Moran, A. J., J. D. Treit, J. L. Whitney, B. Abomoelak, R. Houghton, Y. A. Skeiky, D. P. Sampaio, R. Badaro, and F. E. Nano. 2001. Assessment of the serodiagnostic potential of nine novel proteins from Mycobacterium tuberculosis. FEMS Microbiol. Lett.198:31-36.","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_2_27_2","first-page":"310","volume":"3","year":"1999","unstructured":"Netto, E. M., C. Dye, and M. C. Raviglione. 1999. Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. Int. J. Tuberc. Lung Dis.3:310-320.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(94)90693-9","volume":"344","year":"1994","unstructured":"Okwera, A., C. Whalen, F. Byekwaso, M. Vjecha, J. Johnson, R. Huebner, R. Mugerwa, and J. Ellner. 1994. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration. Lancet344:1323-1328.","journal-title":"Lancet"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.138.1.293","volume":"138","year":"1987","unstructured":"Orme, I. M. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol.138:293-298.","journal-title":"J. Immunol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00006454-200112000-00013","volume":"20","year":"2001","unstructured":"Raja, A., U. D. Ranganathan, R. Bethunaickan, and V. Dharmalingam. 2001. Serologic response to a secreted and a cytosolic antigen of Mycobacterium tuberculosis in childhood tuberculosis. Pediatr. Infect. Dis. J.20:1161-1164.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_31_2","first-page":"515","volume":"70","year":"1992","unstructured":"Raviglione, M. C., J. P. Narain, and A. Kochi. 1992. HIV-associated tuberculosis in developing countries: clinical features, diagnosis and treatment. Bull. W. H. O.70:515-526.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jama.1995.03520270054031","volume":"273","year":"1995","unstructured":"Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA273:220-226.","journal-title":"JAMA"},{"key":"e_1_3_2_33_2","first-page":"149","volume":"70","year":"1992","unstructured":"Sudre, P., G. ten Dam, and A. Kochi. 1992. Tuberculosis: a global overview of the situation today. Bull. W. H. O.70:149-159.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.3.553-557.1997"},{"key":"e_1_3_2_35_2","first-page":"191","volume":"69","year":"1994","unstructured":"World Health Organization. 1994. The current global situation of the HIV\/AIDS pandemic. Wkly. Epidemiol. Rec.69:191-192.","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/ac00104a020","volume":"67","year":"1995","unstructured":"Yates, J. R., III, J. K. Eng, A. L. McCormack, and D. Schieltz. 1995. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem.67:1426-1436.","journal-title":"Anal. Chem."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.2.280-286.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.2.280-286.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:56:44Z","timestamp":1682650604000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.11.2.280-286.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1128\/CDLI.11.2.280-286.2004"],"URL":"https:\/\/doi.org\/10.1128\/cdli.11.2.280-286.2004","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"2003-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-12-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}